Summary
Arkansas Blue Cross updated coverage criteria for two areas: added coverage for Viltolarsen (Viltepso) for Duchenne Muscular Dystrophy patients aged 4-9, and revised criteria for Coronary CT Angiography (CCTA) with specific new indications for abnormal exercise tests and preoperative cardiac evaluation.
Get alerts when payers change rules like this one
We check Arkansas Blue Cross Blue Shield and other payers every day and email you when a change matches your specialty and state.
Get Arkansas Blue Cross Blue Shield alertsPolicy Monitoring is free. No card required.
What to do
Action · 3 steps
01Before November 15, 2025: Billing team must update prior authorization criteria for Viltolarsen (Viltepso) to include patients aged 4-9 with Duchenne Muscular Dystrophy.
02Update CCTA billing requirements to ensure documentation supports new coverage criteria including abnormal exercise treadmill tests and preoperative cardiac evaluation scenarios.
03Review encounter forms to capture required criteria documentation.
Original notice
Policy Criteria Changes
assets.contentstack.io no longer serves this document. We saved a copy on Nov 7, 2026.
Related changes
See all Arkansas Blue Cross Blue Shield changes →Policy Criteria ChangesMediumEffective Nov 24, 2025 · Medical PolicyPolicy Criteria ChangesLowEffective Nov 15, 2025 · Medical PolicyPolicy Criteria ChangesMediumEffective Nov 15, 2025 · Medical PolicyPolicy Criteria ChangesHighEffective Dec 1, 2025 · Medical PolicyBrowse every Arkansas Blue Cross Blue Shield change in the policy list